John Dawson

Browse news and features about John Dawson, Chief Executive Officer of Oxford Biomedica – a leading gene and cell therapy group focused on developing life-changing treatments for serious diseases, based in Oxfordshire. The company was founded in 1995 as a spin-out from the Department of Biochemistry at the University of Oxford.